Previous reports have shown that FHL2 facilitates cell proliferation in glioblastoma [6], gastric, colon [7], and cervical [8] cancers, but inhibits neuroblastoma [10] and myeloid malignancies [11]. The gene discussed is FHL2; the disease is neuroblastoma.